A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1Keisuke Enomoto, Muneki Hotomi|Scientific Reports|2019Cited by 59
Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical ModelsKeisuke Enomoto, Muneki Hotomi|Cancers|2021Cited by 10
MicroRNA 200b promotes mesenchymal‑to‑epithelial transition in anaplastic thyroid carcinomaShunji Tamagawa, Muneki Hotomi|Oncology Letters|2020Cited by 3